Medicine and Dentistry
Malignant Neoplasm
84%
Head and Neck Cancer
78%
Oropharynx Squamous Cell Carcinoma
76%
Overall Survival
72%
Oropharynx Carcinoma
69%
Oral Cavity
58%
Squamous Cell Carcinoma
47%
Oral Cancer
46%
Diseases
44%
Neoplasm
44%
Hazard Ratio
41%
Wart Virus
40%
Robot-Assisted Surgery
37%
Systematic Review
37%
Surgery
36%
Neck
36%
Proportional Hazards Model
31%
Quality Improvement
28%
Hypopharynx
28%
Comorbidity
28%
Laryngoscopy
26%
Plummer-Vinson Syndrome
25%
Head and Neck Squamous Cell Carcinoma
22%
P16
22%
Free Tissue Graft
20%
Adjuvant Therapy
18%
Liquorrhea
18%
Second Cancer
18%
Radiation Therapy
18%
Otorhinolaryngology
18%
Rhabdomyosarcoma
18%
Intubation
18%
Laryngectomy
18%
Operating Room
18%
Observational Study
18%
Nasopharynx Carcinoma
18%
Free Flap Reconstructive Surgery
18%
Pituitary Adenoma
18%
Skull Base
18%
Cohort Effect
18%
Patient Safety
18%
Gene Mutation
18%
Fiber Optics
18%
Xerostomia
18%
Plexiform Neurofibroma
18%
Neurinoma
18%
Surgical Margin
18%
Neuroanatomy
18%
Sphenoid
18%
Side Effect
18%
Keyphrases
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
100%
Head-and-neck Cancer
78%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
58%
Oral Cavity Cancer
40%
National Cancer Database
40%
Transoral Robotic Surgery
37%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
34%
Overall Survival
32%
5-year Survival
29%
Dysphagia
27%
Head-and-neck
24%
High-risk Human Papillomavirus (HR-HPV)
23%
Tumor
23%
Flexible Endoscopy
22%
Nasopharyngeal Carcinoma
22%
Histological Subtypes
21%
Hypopharynx
21%
Hazard Ratio
20%
Confidence Interval
19%
Survival Disparities
18%
Human Papillomavirus Negative
18%
Consulting Services
18%
Laryngoscopic View
18%
Molecular Margins
18%
Radiation Therapy
18%
Cancer Inpatients
18%
Clinical Impact
18%
Surgical Time
18%
Otolaryngology Residency Application
18%
Microvascular Free Flap
18%
Genetic mutation
18%
Optical Fiber
18%
Neck Breather
18%
Second Primary
18%
Attending Physicians
18%
P16+
18%
Operating Room Time
18%
Reconstructive Surgery
18%
Adjusted Hazard Ratio
18%
Incision
18%
TP53 mutation
18%
Non-smoking
18%
Free Flap
18%
Sinonasal Rhabdomyosarcoma
18%
Prognostic Significance
18%
Functional Assessment of Cancer Therapy
18%
Treatment Side Effects
18%
Single-item Indicators
18%
Bother
18%
Immersive Virtual Reality
18%